Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
Department of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.
Biomarkers. 2020 Mar;25(2):144-148. doi: 10.1080/1354750X.2020.1713214. Epub 2020 Jan 20.
Few studies have investigated haem oxygenase-1 gene (HMOX1) promoter polymorphism in microvascular angina (MVA). HMOX1 promoter (GT) repeats were examined in healthy controls ( = 220) and MVA subjects ( = 181). The distribution of genotype of SS, SL and LL were significantly different in MVA (17%, 51%, 33%) vs. normal controls (35%, 46%, 20%) ( < 0.001, S allele: ≤30 repeats, L allele: >30 repeats). In multivariate analysis, carrier of L allele (odds ratio 2.772, < 0.001) was a significant predictor for the diagnosis of MVA. Subjects with MVA had longer HMOX1 promoter (GT) repeats than the healthy controls. : NCT01198730 at https://clinicaltrials.gov.
鲜有研究调查过微血管性心绞痛(MVA)中血红素加氧酶-1 基因(HMOX1)启动子多态性。在健康对照组(n=220)和 MVA 患者组(n=181)中,我们检测了 HMOX1 启动子(GT)重复序列。在 MVA 患者(SS 基因型:17%,SL 基因型:51%,LL 基因型:33%)与正常对照组(SS 基因型:35%,SL 基因型:46%,LL 基因型:20%)中,基因型的分布存在显著差异( < 0.001,S 等位基因:≤30 个重复序列,L 等位基因:>30 个重复序列)。多变量分析显示,L 等位基因携带者(比值比 2.772, < 0.001)是 MVA 诊断的一个显著预测因子。MVA 患者的 HMOX1 启动子(GT)重复序列比健康对照组更长。NCT01198730 可在 https://clinicaltrials.gov 上查阅。